Recombinant growth differentiation factor 11 (Elevian)

重组Growth/differentiation factor 11 replacements (Elevian)

Report date: 2024/12/30 13:26:31

Base Information

Drug NameRecombinant growth differentiation factor 11 (Elevian)
Drug Alias NamerGDF-11
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGrowth/differentiation factor 11 replacements
TargetsGrowth/differentiation factor 11
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Heart Failure +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard University
China Registration ClassN/A

Develop Information

Active CompaniesHarvard University
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Heart Failure +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A